Novo Nordisk A/S — Form 6-K summary
Reporting context: The filing is a share repurchase programme update dated October 12, 2026, covering transactions through October 9, 2026. Although the request metadata lists October 12, 2023, the filing itself is dated October 12, 2026.
Key programme and financial figures
- Novo Nordisk began the current repurchase programme on May 6, 2026. It may repurchase up to DKK 11.2 billion under this programme through February 1, 2027.
- The programme is part of an overall share repurchase programme of up to DKK 15 billion during the 12 months beginning February 4, 2026.
- As of October 9, the May programme had repurchased 23.09 million B shares for DKK 6.759 billion.
- Across the overall programme, Novo Nordisk had repurchased 37,849,179 B shares since February 4, at an average price of DKK 278.97 per share and a total transaction value of DKK 10.559 billion.
- The company held 51,889,876 B shares as treasury shares, equal to 1.2% of share capital. Total A and B shares, including treasury shares, were 4.465 billion.
| Transaction date | B shares repurchased | Average price (DKK) | Transaction value (DKK) |
|---|---|---|---|
| October 5, 2026 | 245,000 | 246.39 | 60,365,707 |
| October 6, 2026 | 250,000 | 247.50 | 61,874,647 |
| October 7, 2026 | 250,000 | 250.87 | 62,717,325 |
| October 8, 2026 | 250,000 | 251.66 | 62,914,296 |
| October 9, 2026 | 250,000 | 254.93 | 63,733,579 |
Changes, outlook, and other disclosures
- For the five reported trading days, the company repurchased 1.245 million shares for approximately DKK 311.6 million. The filing provides the accumulated total since the prior announcement for comparison: 21.845 million shares and DKK 6.447 billion.
- The company expects repurchases of up to DKK 15 billion over the stated 12-month period. This is a programme limit, not an earnings or operating forecast.
- The filing reports no revenue, profit, cash flow, margin, debt, or liquidity figures, and provides no operating guidance or discussion of contingencies.
- The programme is stated to operate under the EU Market Abuse Regulation safe-harbour rules. Transaction-level details are available on the company’s website.
Important facts for investors to verify
- Confirm the reporting date: the filing text says October 12, 2026, despite the request metadata’s 2023 period.
- Track repurchases against both the DKK 11.2 billion programme cap and the overall DKK 15 billion limit, noting the different start dates and scopes.
- Verify subsequent repurchase activity and treasury-share totals in later company announcements.